Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Thoracic Cancer|January 25, 2021
Tofacitinib overcomes an IFNγ-induced decrease in NK cell-mediated cytotoxicity via the regulation of immune-related molecules in LC-2/adRiki Okita, Katsuhiko Shimizu, Yuji Nojima, et al.
Oncotarget|December 13, 2019
Clinicopathological relevance of tumor expression of NK group 2 member D ligands in resected non-small cell lung cancerRiki Okita, Ai Maeda, Katsuhiko Shimizu, et al.
World Journal of Surgical Oncology|October 2, 2015
Preoperative neutrophil/lymphocyte ratio and prognostic nutritional index predict survival in patients with non-small cell lung cancerKatsuhiko Shimizu, Riki Okita, Shinsuke Saisho, et al.
Cancer Management and Research|December 15, 2017
Prognostic value of Cox-2 and PD-L1 expression and its relationship with tumor-infiltrating lymphocytes in resected lung adenocarcinomaKatsuhiko Shimizu, Riki Okita, Shinsuke Saisho, et al.
Oncology Reports|June 8, 2019
Effect of platinum‑based chemotherapy on the expression of natural killer group 2 member D ligands, programmed cell death‑1 ligand 1 and HLA class I in non‑small cell lung cancerRiki Okita, Ai Maeda, Katsuhiko Shimizu, et al.
Cancer Immunology, Immunotherapy : CII|March 26, 2017
PD-L1 overexpression is partially regulated by EGFR/HER2 signaling and associated with poor prognosis in patients with non-small-cell lung cancerRiki Okita, Ai Maeda, Katsuhiko Shimizu, et al.
Oncotargets and Therapy|January 19, 2017
Clinicopathological and immunohistochemical features of lung invasive mucinous adenocarcinoma based on computed tomography findingsKatsuhiko Shimizu, Riki Okita, Shinsuke Saisho, et al.
Oncology Letters|August 10, 2017
Urinary levels of prostaglandin E2 are positively correlated with intratumoral infiltration of Foxp3+ regulatory T cells in non-small cell lung cancerKatsuhiko Shimizu, Riki Okita, Shinsuke Saisho, et al.
Therapeutics and Clinical Risk Management|May 24, 2019
Comparative study of the PD-L1 expression and CD8+ tumor-infiltrating lymphocyte between surgically resected and matched re-biopsy specimens in recurrent non-small cell lung cancerKatsuhiko Shimizu, Riki Okita, Shinsuke Saisho, et al.
Anticancer Research|August 1, 2018
Impact of COX2 Inhibitor for Regulation of PD-L1 Expression in Non-small Cell Lung CancerKatsuhiko Shimizu, Riki Okita, Shinsuke Saisho, et al.
Pageof 3